Tag Archives: Emerald Health Therapeutics Inc.

Emerald Health Northern Vine Labs

Northern Vine Labs Expands Dealer’s License with Health Canada

Northern Vine Labs Expands Dealer’s License with Health Canada

VICTORIA, British Columbia, Dec. 15, 2017 /Weed Wire/ — Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE: ATT; OTC: ATTBF), today announced that Health Canada has approved an amendment to the Company’s dealer’s license.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery of THCA Cannabinoid’s Neuroprotective Treatment Potential

VICTORIA, British Columbia, Sept. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF), a Canadian licensed medical producer of cannabis, is pleased to report that members of its scientific advisory team have made a novel discovery highlighting the potential of tetrahydrocannabinolic acid (THCA), a naturally occurring non-psychotropic cannabinoid, to treat Huntington’s disease and other metabolic, neurodegenerative and neuroinflammatory diseases.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

VICTORIA, British Columbia, Sept. 18, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (Therapeutics) (TSXV: EMH; OCTQX: EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product.


Top